Close
4

Athena Athena

X

Find Leriglitazone manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Looking for 146062-44-4 / Leriglitazone API manufacturers, exporters & distributors?

Leriglitazone manufacturers, exporters & distributors 1

10

PharmaCompass offers a list of Leriglitazone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Leriglitazone manufacturer or Leriglitazone supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Leriglitazone manufacturer or Leriglitazone supplier.

PharmaCompass also assists you with knowing the Leriglitazone API Price utilized in the formulation of products. Leriglitazone API Price is not always fixed or binding as the Leriglitazone Price is obtained through a variety of data sources. The Leriglitazone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Leriglitazone

Synonyms

146062-44-4, Hydroxy pioglitazone (m-iv), Min-102, Chebi:82937, Leriglitazone [usan], 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione

Cas Number

146062-44-4

Unique Ingredient Identifier (UNII)

K824X25AYA

About Leriglitazone

Leriglitazone is under investigation in clinical trial NCT03917225 (A Clinical Study to Evaluate the Effect of MIN-102 on the Progression of Friedreich's Ataxia in Male and Female Patients).

Leriglitazone Manufacturers

A Leriglitazone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Leriglitazone, including repackagers and relabelers. The FDA regulates Leriglitazone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Leriglitazone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Leriglitazone Suppliers

A Leriglitazone supplier is an individual or a company that provides Leriglitazone active pharmaceutical ingredient (API) or Leriglitazone finished formulations upon request. The Leriglitazone suppliers may include Leriglitazone API manufacturers, exporters, distributors and traders.

Leriglitazone GMP

Leriglitazone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Leriglitazone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Leriglitazone GMP manufacturer or Leriglitazone GMP API supplier for your needs.

Leriglitazone CoA

A Leriglitazone CoA (Certificate of Analysis) is a formal document that attests to Leriglitazone's compliance with Leriglitazone specifications and serves as a tool for batch-level quality control.

Leriglitazone CoA mostly includes findings from lab analyses of a specific batch. For each Leriglitazone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Leriglitazone may be tested according to a variety of international standards, such as European Pharmacopoeia (Leriglitazone EP), Leriglitazone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Leriglitazone USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY